학술논문
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study
Document Type
Article
Author
Jabbour, Elias; Short, Nicholas J; Ravandi, Farhad; Huang, Xuelin; Daver, Naval; DiNardo, Courtney D; Konopleva, Marina; Pemmaraju, Naveen; Wierda, William; Garcia-Manero, Guillermo; Sasaki, Koji; Cortes, Jorge; Garris, Rebecca; Khoury, Joseph D; Jorgensen, Jeffrey; Jain, Nitin; Alvarez, Joie; O'Brien, Susan; Kantarjian, Hagop
Source
In The Lancet Haematology December 2018 5(12):e618-e627
Subject
Language
ISSN
2352-3026